Clinical Trial Update: Hypofractionation (Radiation) Trial for Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at the University of Chicago is evaluating hypofractionation radiation therapy for multiple myeloma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Chicago | Conditions: Multiple Myeloma | Phase 1 | Status: RECRUITING